Depending on these results, we inferred that lncRNA LINC00152 down-regulation have anti-tumor effects via inhibiting EGFR/PI3K/AKT pathway and enhancing P21 expressions in esophageal cancer. The gene discussed is EGFR; the disease is neoplasm.